254 related articles for article (PubMed ID: 23810735)
1. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis.
Lim HJ; Park JS; Cho YJ; Yoon HI; Park KU; Lee CT; Lee JH
Tuberculosis (Edinb); 2013 Sep; 93(5):523-8. PubMed ID: 23810735
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
Li N; Xie WP; Kong H; Min R; Hu CM; Zhou XB; Lu ZM; Ji XH; Wang H
Int J Tuberc Lung Dis; 2015 Oct; 19(10):1230-8. PubMed ID: 26459539
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Circulating CD4
Ferrian S; Ross M; Conradie F; Vally Omar S; Ismail N; Little F; Kaplan G; Fallows D; Gray CM
Front Immunol; 2018; 9():2438. PubMed ID: 30410488
[TBL] [Abstract][Full Text] [Related]
4. Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis.
Wu YE; Peng WG; Cai YM; Zheng GZ; Zheng GL; Lin JH; Zhang SW; Li K
Int J Infect Dis; 2010 Sep; 14(9):e815-22. PubMed ID: 20655262
[TBL] [Abstract][Full Text] [Related]
5. CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis.
Ndishimye P; Zakham F; Musanabaganwa C; Migambi P; Mihai C; Soritau O; El Mzibri M; Pop CM; Mutesa L
Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):18-22. PubMed ID: 32133974
[TBL] [Abstract][Full Text] [Related]
6. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
[TBL] [Abstract][Full Text] [Related]
7. Effective expansion of forkhead box P3⁺ regulatory T cells via early secreted antigenic target 6 and antigen 85 complex B from Mycobacterium tuberculosis.
Wu YE; Du ZR; Cai YM; Peng WG; Zheng GZ; Zheng GL; Wu LB; Li K
Mol Med Rep; 2015 Apr; 11(4):3134-42. PubMed ID: 25483347
[TBL] [Abstract][Full Text] [Related]
8. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
[TBL] [Abstract][Full Text] [Related]
9. [Expression of mRNA transcription factors RORC2 and FoxP3 in lymphocytes in patients with pulmonary tuberculosis].
Kononova TE; Urazova OI; Novitskiĭ VV; Churina EG; Zakharova PA
Tsitologiia; 2015; 57(1):56-61. PubMed ID: 25872376
[TBL] [Abstract][Full Text] [Related]
10. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
[TBL] [Abstract][Full Text] [Related]
11. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
12. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
[TBL] [Abstract][Full Text] [Related]
13. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
14. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
15. [The changes and the significance of cellular immune function in peripheral blood of patients with multidrug-resistant and extensively drug-resistant pulmonary tuberculosis].
Yang Y; Tang SJ; Zhang Q; Sun H; Liu YD; Hao XH; Yao L; Gu J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Feb; 34(2):109-13. PubMed ID: 21426728
[TBL] [Abstract][Full Text] [Related]
16. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
[TBL] [Abstract][Full Text] [Related]
17. Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10.
Xu L; Cui G; Jia H; Zhu Y; Ding Y; Chen J; Lu C; Ye P; Gao H; Li L; Ma W; Lyu J; Diao H
J Transl Med; 2016 Jun; 14(1):179. PubMed ID: 27311307
[TBL] [Abstract][Full Text] [Related]
18. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.
Cağatay T; Kiran B; Yurt S; Gülbaran Z; Kosar F; Cağatay P
Respirology; 2005 Jun; 10(3):290-4. PubMed ID: 15955139
[TBL] [Abstract][Full Text] [Related]
19. Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.
Lee J; Lim HJ; Cho YJ; Park YS; Lee SM; Yang SC; Yoo CG; Kim YW; Han SK; Yim JJ
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1331-3. PubMed ID: 22283890
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
